Cargando…
The impact and effectiveness of pneumococcal vaccination in Scotland for those aged 65 and over during winter 2003/2004
BACKGROUND: For winter 2003/2004 in Scotland, it was recommended that all those aged 65 and over be eligible to receive 23-valent polysaccharide pneumococcal vaccine (23vPPV), which has been shown to be effective in reducing the risk of invasive pneumococcal disease (IPD). We assessed the success of...
Autores principales: | Mooney, John D, Weir, Amanda, McMenamin, Jim, Ritchie, Lewis D, Macfarlane, Tatania V, Simpson, Colin R, Ahmed, Syed, Robertson, Chris, Clarke, Stuart C |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2386805/ https://www.ncbi.nlm.nih.gov/pubmed/18433473 http://dx.doi.org/10.1186/1471-2334-8-53 |
Ejemplares similares
-
Modelling the population effectiveness of the national seasonal influenza vaccination programme in Scotland: The impact of targeting all individuals aged 65 years and over
por: Corson, Stephen, et al.
Publicado: (2019) -
Death or survival from invasive pneumococcal disease in Scotland: associations with serogroups and multilocus sequence types
por: Inverarity, Donald, et al.
Publicado: (2011) -
SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness
por: Sheikh, Aziz, et al.
Publicado: (2021) -
Severity of omicron variant of concern and effectiveness of vaccine boosters against symptomatic disease in Scotland (EAVE II): a national cohort study with nested test-negative design
por: Sheikh, Aziz, et al.
Publicado: (2022) -
Uptake and effectiveness of influenza vaccine in those aged 65 years and older in the United Kingdom, influenza seasons 2010/11 to 2016/17
por: Pebody, Richard G, et al.
Publicado: (2018)